Answers are grounded in this paper and cite their sources.
The development of tumor necrosis factor (TNF) antagonists has revolutionized the treatment of inflammatory bowel disease (IBD). Paradoxically, TNF antagonists can also induce inflammation, such as psoriasis induced by TNF antagonists. The mechanisms by which TNF antagonists induce paradoxical inflammation, has remained largely unresolved. In this review we will focus on the immunologic effects of the therapy with TNF antagonists and give an overview of TNF antagonist-induced immunologically mediated diseases.
No takes yet. Share an insight, caveat, or question.
Jan Hendrik Niess (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: